openPR Logo
Press release

Global Biosimilars Market Competitive Landscape, Capital Share Analysis and Forecast Revenue 2022-2031

06-15-2022 03:08 PM CET | Health & Medicine

Press release from: The Business research company

Biosimilars Market

Biosimilars Market

The global biosimilars market size is expected to grow from $15.67 billion in 2021 to $19.10 billion in 2022 at a compound annual growth rate (CAGR) of 21.8%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The biosimilar market is expected to reach $42.30 billion in 2026 at a CAGR of 22%.

The Business Research Company offers the Biosimilars Global Market Report 2022 in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market's historic and forecast growth, and highlights important trends and strategies that players in the market can adopt.

Directly purchase the report here: https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2807

The biosimilars market consists of sales of biosimilars and related services that are used to treat chronic diseases such as diabetes, arthritis, and cancer. Biosimilars are pharmaceuticals that are manufactured using cell lines and offer no clinical difference as compared to biologics. Biosimilars are made once the patent of biologics is expired.

Some key Biosimilars market players are Pfizer, Amgen, Biocon, Celltrion, Dr. Reddy's Laboratories, Boehringer Ingelheim, Elli Lilly and Company, Mylan N.V., Sanofi, STADA Arzneimittel, Sandoz International, Samsung Bioepis, Teva Pharmaceuticals, Apotex, AMEGA Biotech S.A., Bioton S.A., Innovent Biologics International, Allergan plc, BioXpress Therapeutics, 3SBio, Intas Biopharmaceuticals, Lupin Merck, Novartis, Ratiopharm, Wockhardt, Zydus Cadila, Allergan Plc., Hospira International., Actavis International., Johnson & Johnson and Roche.

The countries covered in the global Biosimilars market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.

The regions covered in the global Biosimilars market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Biosimilars Market Segmentation:
1) By Product:
Recombinant Non-glycosylated Proteins
Recombinant Glycosylated Proteins

2) By Type:
Human Growth Hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor

3) By Application:
Oncology
Chronic and Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases

See more on the report at https://www.thebusinessresearchcompany.com/report/biosimilar-global-market-report

The Report's Table Of Contents includes
1. Executive Summary
2. Biosimilars Market Characteristics
3. Biosimilars Market Trends And Strategies
4. Impact Of COVID-19 On Biosimilars
5. Biosimilars Market Size And Growth
....
26. Africa Biosimilars Market
27. Biosimilars Market Competitive Landscape And Company Profiles
28. Biosimilars Pipeline Analysis
29. Key Mergers And Acquisitions In The Biosimilars Market
30. Biosimilars Market Future Outlook and Potential Analysis
31. Appendix

This report covers the trends and market dynamics of the Biosimilars market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Request for a Sample of this report: https://www.thebusinessresearchcompany.com/sample.aspx?id=2807&type=smp

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our blog: http://blog.tbrc.info/
And follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

About Us:
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. It has published over 3000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Biosimilars Market Competitive Landscape, Capital Share Analysis and Forecast Revenue 2022-2031 here

News-ID: 2653877 • Views: 258

More Releases from The Business research company

Luxury Hair Care Products Market Size Report 2022-2031: Industry Share, Trends, …
The global luxury hair care market is expected to grow from $19.27 billion in 2021 to $20.62 billion in 2022 at a compound annual growth rate (CAGR) of 7.1%. The global luxury hair care market is expected to grow to $27.22 billion in 2026 at a compound annual growth rate (CAGR) of 7.2%. The Business Research Company offers the Luxury Hair Care Global Market Report 2022 in its research report store.
Global Hand Wash Market Drivers, Trends And Opportunities For 2022-2031
The global hand wash market is expected to grow from $10.77 billion in 2021 to $12.10 billion in 2022 at a compound annual growth rate (CAGR) of 12.4%. The global hand wash market is expected to grow to $15.95 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The Business Research Company offers the Hand Wash Global Market Report 2022 in its research report store. It is the
Biomass Gasification Market 2022 : By Technology, Application, Global Analysis A …
The global biomass gasification market size is expected to grow from $90.56 billion in 2021 to $98.63 billion in 2022 at a compound annual growth rate (CAGR) of 8.9%. The global biomass gasification market size is expected to grow to $139.49 billion in 2026 at a compound annual growth rate (CAGR) of 9.1%. The Business Research Company offers the Biomass Gasification Global Market Report 2022 in its research report store.
Aerostructures Market 2022 Global Key Players, Industry Analysis, Potential Grow …
The global aerostructures market size is expected to grow from $47.76 billion in 2021 to $51.04 billion in 2022 at a compound annual growth rate (CAGR) of 6.9%. The global aerostructures market size is expected to grow to $67.25 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The Business Research Company offers the Aerostructures Global Market Report 2022 in its research report store. It is the most

All 5 Releases


More Releases for Biosimilars

Global Biosimilars Market 2021-2028 | Price Advantage of Biosimilars Over Biolog …
The global Biosimilars market focuses on encompassing major statistical evidence for the Biosimilars industry as it offers our readers a value addition on guiding them in encountering the obstacles surrounding the market. A comprehensive addition of several factors such as global distribution, manufacturers, market size, and market factors that affect the global contributions are reported in the study. In addition, the Biosimilars study also shifts its attention with an in-depth
Growth of the Biosimilars Market Is Mainly Driven by Increasing Number of Approv …
A biosimilar is a biologic medical product that is similar to another already approved biological medicine, in terms of quality, safety, and efficacy. Biosimilars are a class of therapeutic drugs that provide additional treatment options and help reduce healthcare costs. Thus, there is an increasing demand for biosimilar drugs due to increasing prevalence of autoimmune diseases, key factor driving the growth of the biosimilars market. According to the National Stem
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure. According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is
Global Biosimilars Market | Global Biosimilars Industry | Global Biosimilars Mar …
The biosimilars market involves of sales of biosimilars and associated services that are cast-off to treat chronic sicknesses such as diabetes, arthritis, and cancer. The Biosimilars are pharmaceuticals that are produced using cell lines and offers no clinical difference as linked to biologics. The Biosimilars are made once the patent of biologics is deceased. According to the report analysis, ‘Biosimilars Market Global Report 2020-30’ states that the worldwide biosimilars market was
Global Oral Biologics and Biosimilars Market | Global Oral Biologics and Biosimi …
The oral biologics and biosimilar market contain of sales of oral biologics and biosimilar products and associated services utilized to treat chronic syndromes such as diabetes, arthritis, cancer. Biologics are drugs completed from living cells using exceedingly complex technology while biosimilars are generated to function similarly to biologics but are not matching to biologics. Biosimilars offer energetic properties as any licensed biologic drug. The oral biologics and biosimilar market encompass
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million